Ares Financial Consulting
PFE icon

Ares Financial Consulting’s Pfizer PFE Stock Holding History

Ares Financial Consulting’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$642K Buy
22,503
+161
+0.7% +$4.28K 0.44% 40
2026
Q2 		$538K Sell
22,342
-43
-0.2% -$1.12K 0.39% 47
2026
Q1 		$639K Buy
22,385
+1,359
+6% +$36.2K 0.5% 36
2025
Q4 		$524K Buy
+21,026
New +$530K 0.5% 43

Other funds holding PFE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $142B AUM 43.93% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Ares Financial Consulting's PFE Position: Q3 2026 in Review

Ares Financial Consulting increased its Pfizer (PFE) stake by 0.72% in Q3 2026, buying an estimated $4.28K and bringing the position to 22,503 shares worth $642K. The position accounts for 0.44% of the portfolio, ranked #40.

Ares Financial Consulting first reported a position in PFE in Q4 2025 and has held it in 4 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Ares Financial Consulting held 22,503 shares of Pfizer worth $642K as of Q3 2026.
  • Ares Financial Consulting bought 161 Pfizer shares in Q3 2026, an estimated $4.28K.
  • Pfizer made up 0.44% of Ares Financial Consulting's portfolio in Q3 2026, its #40 holding.
  • Ares Financial Consulting first reported a position in Pfizer in Q4 2025 and has held it in 4 quarters since.
  • 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.